JUST IN　•　Ars Technica - All content

Most powerful obesity drug yet: People lost up to 25% of weight in trial

SHARE THIS STORYPLUS UNLOCKS FAVORITES READ LATER AND SOURCE CONTROL

Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.

READ ORIGINAL REPORT ↗

THIS JUST HAPPENED PACKAGES THE WORLD INTO A FAST LIVE FEED SOURCE REPORTING STAYS ONE CLICK AWAY

RELATED POSTSMORE HEALTH

HEALTH　•　The Latest News from the UK and Around the World | Sky News

Baby's 'party' drug exposure death to be examined by inquiry in 2027

HEALTH　•　BBC News

Endometriosis trial gives hope to millions of women in pain like me

HEALTH　•　Latest Content - Women's Health

Women’s Health Just Teamed Up With Equip to Research How Weight Bias Impacts PMOS Patients. The Data Is Concerning.

HEALTH　•　BBC News

'People forget we exist': Why older LGBTQ+ people fear losing identity

HEALTH　•　Ars Technica - All content

To keep drug prices high, pharma has been piling up the patents

HEALTH　•　Latest Content - Cosmopolitan

Fans Think They Spotted Travis Kelce Lurking in the Background of the “Patient Zero” Music Video

HEALTH　•　BBC News

How empty chairs are helping people's mental health

HEALTH　•　BBC News

'My big breasts lead to lewd comments in the street'